Bone density is compromised in amenorrheic women despite return of menses: a 2-year study. Obstet Gynecol 1993; 81: 669–74 PubMed CAS Google Scholar Burkman RT, Collins JA, Greene RA. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol 2001 Aug...
Andersson B, Mattsson L, Hahn L, et al. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin dependent diabetes mellitus. J Clin Endocrinol Metab 1997;82:638-43....
In his new book “The Estrogen Window,” Dr. Seibel presents groundbreaking research which explains that every woman has a window of opportunity to begin estrogen replacement. This critically acclaimed book clears the confusion and provides easy to understand facts and tips to help women decide ...
Further, some preliminary results suggest that in a clinical setting, short-term E2 treatment is able to reduce plasma levels of Aβ in post-menopausal women naïve to HT [20], although the significance of plasma Aβ in terms of both AD pathogenesis and diagnostic value remains controversial...
(deep venous thrombosis, pulmonary embolism). In addition,estrogen therapyis not advised for patients with breast cancer, over 60% of whom receive an antiestrogenic drug (usually tamoxifen) as part of their cancer treatment. In these women, lack of estrogen may result in worsening or resurgence...
A. et al. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women. Menopause Int. 13, 124–131 (2007). Article CAS PubMed Google Scholar Wang, Y., Wang, Y., Liu, L. & Cui, H. Ovariectomy induces abdominal fat accumulation by improving ...
What is Bioidentical Hormone Therapy? Bioidentical hormones are a form of hormone therapy that has existed since the 1930s and has had resurgence in popularity over the last two decades. Bioidentical hormone replacement therapy has helped thousands of men and women enjoy a healthier, higher qualit...
Along this line, 41% of postmenopausal women become hypertensive, while more than 75% of women older than 60 years are hypertensive in the USA [10]. The majority of women older than 60 years has stage 2 HTN (BP ≥ 160/100 mmHg) or receives antihypertensive therapy [11,12,13]....
et al. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/progestin Replacement Study (HERS) trial. JAMA.2002;287:591-597.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=entrez/...
Liu L, Klein L, Eaton C et al (2020) Menopausal hormone therapy and risks of first hospitalized heart failure and its subtypes during the intervention and extended postintervention follow-up of the women’s health initiative randomized trials. J Card Fail 26:2–12 Article PubMed Google Scholar...